Both in Pharmaceuticals
Aktis Oncology vs Corvus Pharmaceuticals
Over the past year AKTS returned −33.3% and CRVS returned +44.8%; their daily moves had a correlation of 0.09.
AKTS −33.3% CRVS +44.8%Growth of $1, one year, split-adjusted
| Metric | AKTS | CRVS |
|---|---|---|
| Price | $14.94 | $9.83 |
| Market cap | $831.0M | $826.9M |
| Today | +2.40% | +1.34% |
| 1 month | −19.3% | −8.5% |
| 6 months | −23.1% | −37.4% |
| Year to date | — | +27.7% |
| 1 year | — | +22.3% |
| Revenue growth (YoY) | — | — |
| Gross margin | 100.0% | — |
| Net margin | −713.5% | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $517.3M | $215.2M |
| Dividend yield | — | — |
| Volatility (60d) | 55.5% | 52.1% |
| Short % of float | 18.3% | 25.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).